April 20, 2023, St. Petersburg, Florida – Water Tower Research LLC (www.watertowerresearch.com), is modernizing Investor Relations through research-driven communication and investor engagement. WTR is pleased to announce that Sally Yanchus has joined the firm as Senior Research Analyst of Life Sciences.
Commenting on the addition of Sally Yanchus, Charlie Phippen, Chief Executive Officer, stated, “We are very excited to add someone of Sally’s caliber to the Water Tower Research team as we expand our presence in the healthcare sector. Both her buy- and sell-side experience will immediately add value to our business by providing an incredibly knowledgeable resource to both our clients and investors.”
Executive Chairman Stu Linde also commented on the hire, saying, “Water Tower Research continues to exhibit significant growth. The addition of Sally adds to our ongoing momentum in driving a new model for the evolving equity research market that creates substantial content, broader distribution to all investors, and further expands our healthcare footprint.”
With more than 30 years of proven success in equity research, Sally has spent the last two years as VP, Finance at Pneuma Respiratory. Widely recognized as a leading biotech and healthcare analyst, her experience at both buy- and sell-side firms includes Brookline Capital Markets, Tradewinds Global Investors, Bessemer Investments, Galleon Group, Zurich Scudder Investments, Oppenheimer & Co., Punk, Ziegel, & Knoll, Lehman Brothers, and Morgan Stanley. Sally has also spent time as a consultant for several hedge fund clients and independent firms.
Sally earned a BA degree from Wellesley College in Massachusetts and an MBA from the Columbia Business School in New York.
About Water Tower Research (WTR)
Water Tower Research is modernizing Investor Relations through research-driven communications and Investor Engagement. Sound investment research begins with good information. At WTR, we help companies and investors connect by creating expert information flow and strategies that are the foundation of a successful modern investor relations platform. Our analysts and capital markets professionals bring decades of unrivaled Wall Street experience and insight to a new digital world of investor communications and engagement. Our research and investor content is distributed across traditional research aggregators like Bloomberg, FactSet, etc., proprietary direct distribution lists, social media, search engines, and our website. As a result, every institutional and retail investor has equal access to our high-quality company research. Our mission is to help companies take control of their IR program and proactively reach investors while bringing investors a consistent flow of quality information to help them understand our clients’ businesses, industries, and the investment opportunities they present.